← Scoopfeeds — Intelligent news, curated.
Morgan Stanley downgrades Aardvark Therapeutics stock rating on FDA hold
business

Morgan Stanley downgrades Aardvark Therapeutics stock rating on FDA hold

Investing.com · May 15, 2026, 8:23 AM · Also reported by 1 other source

Morgan Stanley downgrades Aardvark Therapeutics stock rating on FDA hold

Read full story on Investing.com → More top stories

Also covered by

Bloomberg Markets Morgan Stanley Upbeat on South Africa Outlook Despite Oil Shock

More in business

CNBC
30-year Treasury yield tops 5.1%, highest in nearly a year
Decrypt
Dune Analytics Slashes 25% of Workforce in AI, Institutional Pivot
Investing.com
Cantor Fitzgerald reiterates Freshworks stock rating on IT expansion
Investing.com
Freedom Broker upgrades Eagle Financial Services stock rating to buy
Investing.com
Cantor Fitzgerald raises GH Research stock price target on adoption outlook
Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop